PUT - SPRINTER OPEN END - AMGEN | Market Closed - Boerse Frankfurt Warrants 01:46:03 2024-05-28 pm EDT | ||
| 3.32 EUR | +35.51% |
|
| Current month | -43.25% | ||
| 1 month | -46.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 3.32 | +35.51% |
| 24-05-27 | 2.45 | -6.49% |
| 24-05-24 | 2.62 | +6.50% |
| 24-05-23 | 2.46 | +21.78% |
| 24-05-22 | 2.02 | -3.35% |
Real-time Boerse Frankfurt Warrants
Last update May 28, 2024 at 01:46 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM77PK |
| ISIN | DE000VM77PK1 |
| Date issued | 2024-01-09 |
| Strike | 334.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7 € |
|---|---|
| Lowest since issue | 1.12 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
